John Rougas
5Patents
2h-index
15Co-inventors
40Inventor score
Filing activity: Oct 22, 2001 → Jul 16, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7153867B2 | Use of nitrogen substituted thalidomide analogs for the treatment of macular degenerator | Human Necessities | 16 | Expired |
| US7812169B2 | Method of synthesis of 4-amino-thalidomide enantiomers | Emerging Cross-Sectional Technologies | 5 | Active |
| US6673821B2 | Nitrogen heterocycle inhibitors of aspartyl protease | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8153806B2 | Synthesis of 4-amino-thalidomide enantiomers | Emerging Cross-Sectional Technologies | 0 | Active |
| US6696494B2 | &agr;-hydroxyarylbutanamine inhibitors of aspartyl protease | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.